Covid19

Novavax targets May approval for COVID-19 vaccine in the U.S. | Fierce Biotech

Novavax is targeting a second-quarter FDA filing for emergency use of its COVID-19 vaccine. The goal suggests the U.S. could join the U.K. on the …

Read more at www.fiercebiotech.com

Show More

Related Articles

Back to top button